The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.00
Bid: 110.50
Ask: 112.50
Change: 0.00 (0.00%)
Spread: 2.00 (1.81%)
Open: 115.50
High: 119.50
Low: 110.50
Prev. Close: 111.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Trading Update

2 May 2019 07:00

RNS Number : 8667X
McBride PLC
02 May 2019
 

2 May 2019

 

McBride plc

 

Directorate Change and Trading Update

 

Directorate Change

 

McBride plc (the "Company") announces that Rik De Vos, CEO, has informed the Board of his decision to leave the Company. A search will commence immediately and Rik has advised the Board that he will remain in position while his successor is being recruited.

 

John Coleman, Chairman, said:

"Rik has brought a strong vision and laid the foundations of the Company's transformation through the "Manufacturing our Future" strategy. I would like to take this opportunity to thank him on behalf of the Board and colleagues for his contribution. I would also like to thank Rik for agreeing to assist the Board to ensure a smooth handover of his responsibilities. The Board wishes him every success in his future endeavours."

 

Rik De Vos, CEO, said:

"In recent years, we have achieved much in a challenging trading environment. We have developed a clear strategy in "Manufacturing our Future" and delivered clear benefits from implementing the "Repair, Prepare, Grow" phases. However, I now consider that the Group requires different leadership to deliver the next phase of its growth ambitions. I'm confident that I will be leaving McBride well positioned to realise these ambitions."

 

An announcement will be made regarding Rik's successor and his departure date in due course.

 

Trading update

 

Following a weak third quarter trading period, the Group now anticipates that its full year earnings will be modestly lower than current market expectations, primarily as a result of weaker than expected sales activity in Germany, France and Italy.

 

The Group expects to provide a trading update for the 12 months ending 30 June 2019 in early July.

 

 

For further information please contact:

McBride plc

John Coleman, Chairman

Chris Smith, CFO

0161 203 7570

FTI Consulting

Ed Bridges, Nick Hasell

020 3727 1017

 

 Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

 

Addendum - CEO Remuneration disclosures

 

Salary and Benefits 

 

Rik will receive payments during his notice period of six months in accordance with his contractual entitlement namely base salary, payments in lieu of pension contributions and benefits. His benefits consist of a company car, private healthcare, disability insurance and life cover. Full details of Rik's contractual entitlements are included in the Remuneration report 2018.

 

Incentives

 

Entitlements to any bonus payment for the current financial year, unvested LTIP entitlements and unvested shares under the deferred bonus plan lapse with this resignation. Full details of unvested awards are included in the Remuneration report 2018.

 

Full details of any relevant payments will be included in the Directors' Remuneration Report for the relevant year. All payments to be made in the notice period are in accordance with the Directors' Remuneration Policy which was approved by shareholders on 24 October 2017.

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUUCAUPBUAP
Date   Source Headline
4th Dec 20183:26 pmRNSIssue of B Shares
3rd Dec 20184:15 pmRNSIssue of B Shares
19th Nov 20187:00 amRNSCompletion of Disposal
31st Oct 20182:40 pmRNSHolding(s) in Company
24th Oct 20184:21 pmRNSResult of AGM
23rd Oct 20187:00 amRNSAGM Trading Update
16th Oct 201812:52 pmRNSHolding(s) in Company
16th Oct 201812:51 pmRNSHolding(s) in Company
12th Oct 20184:48 pmRNSHolding(s) in Company
21st Sep 20183:59 pmRNSAnnual Financial Report and Notice of AGM
14th Sep 20184:09 pmRNSTotal Voting Rights
13th Sep 20185:01 pmRNSDirector/PDMR Shareholding
12th Sep 20184:33 pmRNSNotification and public disclosure of LTIP
12th Sep 20183:49 pmRNSHolding(s) in Company
6th Sep 20187:00 amRNSFinal Results
13th Aug 20184:20 pmRNSHolding(s) in Company
7th Aug 20181:24 pmRNSHolding(s) in Company
3rd Aug 20182:03 pmRNSHolding(s) in Company
10th Jul 20189:12 amRNSHolding(s) in Company
6th Jul 20183:42 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSTrading Update
3rd Jul 20187:00 amRNSSale of European Personal Care liquids
5th Jun 20185:10 pmRNSHolding(s) in Company
5th Jun 201810:24 amRNSIssue of Equity
27th Apr 201812:45 pmRNSHolding(s) in Company
15th Mar 20185:33 pmRNSTR1 - Notification of Major Holdings
12th Mar 20184:54 pmRNSNotification of Major Holdings
2nd Mar 20183:27 pmRNSNotification of Major Holdings
27th Feb 20185:02 pmRNSTotal Voting Rights
27th Feb 20185:02 pmRNSNotification and public disclosure of LTIP
22nd Feb 20187:00 amRNSHalf-year Report
13th Feb 20184:52 pmRNSHolding(s) in Company
11th Jan 20183:50 pmRNSHolding(s) in Company
8th Jan 20187:00 amRNSTrading Update
4th Dec 20174:55 pmRNSIssue of B Shares
16th Nov 201710:40 amRNSHolding(s) in Company
13th Nov 20179:12 amRNSHolding(s) in Company
10th Nov 201710:31 amRNSHolding(s) in Company
25th Oct 20174:35 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20172:30 pmRNSInvestor Day and Site Visits
29th Sep 201712:00 pmRNSCompletion of the acquisition of Danlind a/s
22nd Sep 20174:11 pmRNSAnnual Report and Accounts
22nd Sep 20171:43 pmRNSHolding(s) in Company
13th Sep 20174:00 pmRNSHolding(s) in Company
13th Sep 20172:30 pmRNSDirector/PDMR Shareholding
12th Sep 20174:27 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSAcquisition of Danlind a/s
31st Aug 20174:04 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.